×
Back to Agenda
Day 2 : Session 5 - Compliance Management
Session Chair(s)
Mangesh Kulkarni, MD
Global Head – Drug Safety, Tata Consultancy Services, India
Speaker(s)
Seema Jaitly, DrMed
Managing Director, Sagittal Pharma Consulting Ltd, United Kingdom
Session 5.1: Risk Minimisation Activities & Evalution of Effectiveness
Savitha Hanuman, MPharm
VP. Accenture Life Sciences Operations, Accenture, India
Sesson 5.2: A risk based approach to real time compliance
J Vijay Venkatraman, MD, MBA
Managing Director and CEO, Oviya Medsafe Pvt Ltd, India
Session 5.3 : Indian Pharmacovigilance - Where do we stand today
Have an account?